Introduction
============

Protein crystallography has been the primary source of structural insights into multi-protein complexes for decades. However, only homogenous, stoichiometric, stable, and rigid complexes that are available in sufficient amounts generally form crystals of sufficient quality for X-ray analysis. Therefore, core complexes are often resolved by crystallography whereas the position of additional, peripheral factors remains elusive.

Cross-link analysis can provide positional information on flexible, transient, and modular higher-order multi-protein complexes, by mapping regions of spatial proximity. Cross-linking and mass spectrometry (MS) have first been used for the analysis of a multi-protein complex a decade ago ([@b44]). After long development ([@b49]) cross-link sites are now identified by database searches in a similar way to protein modification sites ([@b36]; [@b47]). This revealed the organization of the 180 kDa Ndc80 complex, the largest complex analysed to date, at peptide resolution ([@b36]) and guided the X-ray analysis of the complex ([@b11]). Here, we show that cross-linking can be used to study even larger complexes in synergy with established structural biology techniques.

We applied our approach to a major unresolved question in molecular biology, the structure of the RNA polymerase II (Pol II) transcription initiation complex. Transcription initiation at eukaryotic protein-coding genes requires Pol II and the basal transcription factors (TFs) IIB, -D, -E, -F, and -H ([@b45]). Although the crystal structure of the 12-subunit Pol II is known ([@b1]), structural information on the complex of Pol II with initiation factors remains limited ([@b35]).

Here, we investigate the structure of Pol II in complex with TFIIF. TFIIF was first identified based on its tight interaction with Pol II ([@b52]). In the yeast *Saccharomyces cerevisiae*, about half of Pol II is bound by TFIIF ([@b41]). Yeast TFIIF comprises the essential subunits Tfg1 and Tfg2, and the non-essential subunit Tfg3 ([@b25]). Human TFIIF consists of homologues to Tfg1 (Rap74) and Tfg2 (Rap30), but lacks a Tfg3 homologue ([@b25]). Rap74 comprises an N-terminal region that binds Rap30 ([@b59]), a charged, central region, and a C-terminal domain that binds the phosphatase Fcp1([@b6]; [@b34]). Rap30 comprises an N-terminal region that binds Rap74 ([@b61]), a central region that binds Pol II ([@b51]; [@b37]), and a C-terminal domain ([@b21]; [@b57]). The N-terminal regions of Rap74 and Rap30 form a dimerization domain with a triple-barrel fold ([@b20]), whereas the C-terminal domains of Rap74 and Rap30 form winged helix (WH) domains ([@b24]; [@b28]).

TFIIF is required for initiation at TATA-containing and TATA-less promoters ([@b4]), reduces the affinity of Pol II to DNA ([@b21]), and prevents interaction of Pol II with non-specific DNA ([@b32]). TFIIF is required for stable pre-initiation complex formation ([@b56]), and for normal start site selection ([@b39]; [@b22]; [@b18]). In initially transcribing complexes, TFIIF stimulates phosphodiester bond formation and stabilizes a short DNA--RNA hybrid ([@b19]; [@b31]). During elongation *in vitro*, TFIIF reduces the time of Pol II pausing ([@b17]; [@b40]; [@b2]; [@b5]; [@b57]) and suppresses backtracking and RNA cleavage induced by TFIIS ([@b15]; [@b62]).

To understand the multiple TFIIF functions, and the architecture of the Pol II initiation complex, detailed structural knowledge of the Pol II--TFIIF complex is required. Electron microscopy (EM) of complexes of Pol II with endogenous TFIIF and recombinant Tfg2 at 18 Å resolution suggested that Tfg2 extends along the polymerase cleft and Tfg1 binds around the Rpb4/7 subcomplex and the clamp on the Rpb1 side of the cleft ([@b10]). Site-specific radical-generating probing however placed TFIIF on the other side of the cleft near Rpb2 ([@b9]).

Here, we used protein cross-linking coupled to MS to first analyse the free, 12-subunit Pol II, a complex of 513 kDa. Agreement of the data with the crystal structure shows for the first time that the method can be applied to such large complexes. This establishes cross-linking coupled to MS as a tool for the structural analysis of large multi-protein complexes. We then apply the approach to the Pol II--TFIIF complex that was purified as a stoichiometrically homogeneous complex from yeast cells using a new protocol. This complex comprises 15 polypeptides and has a total molecular weight of 670 kDa. The resulting detailed map of cross-links between Pol II and TFIIF, together with previous crystallographic data and molecular modelling, unravels the architecture of the Pol II--TFIIF complex and provides insights into the function of TFIIF during transcription.

Results
=======

MS cross-link analysis of Pol II
--------------------------------

To test whether we could extend our cross-link analysis to large multi-protein complexes, we analysed the 12-subunit 513 kDa Pol II, for which a crystal structure is available (PDB 1WCM) ([@b1]). Pol II was obtained as described ([@b54]). 30 μg of Pol II was subjected to cross-linking with the label-free cross-linker Bis (sulphosuccinimidyl) suberate (BS3, Thermo Fisher Scientific) (see Materials and methods). BS3 reacts with primary amines in lysine side chains and protein N-termini. The amines must be \<11.4 Å apart, the maximal length of the BS3 spacer. Adding 16 Å to this, two times the length of a lysine side chain (6--6.5 Å) including an estimated coordinate error for mobile surface residues (1.5 Å), defines the maximal C-α distance of linkable lysine residues, 27.4 Å, when comparing our cross-link data with the available crystallographic data. We used a charge-based enrichment strategy for cross-linked peptides ([@b36]; [@b47]) and high-resolution MS for peptide and fragment detection (see Materials and methods). We identified 146 linkage pairs in 429 mass spectra matching to cross-linked peptides ([Supplementary Tables 1](#S1){ref-type="supplementary-material"} and [2](#S1){ref-type="supplementary-material"}). In our subsequent analysis we focussed on those 106 linkage pairs that had both linked residues present in the Pol II structure.

Our cross-link data reflected accurately the structural features of Pol II. The observed cross-links were significantly different from a random selection of all possible pairs in the structure (*P*-value of 3 × 10^−87^) ([Figure 1D](#f1){ref-type="fig"}). The C-α distances of 99 pairs fell below 27.4 Å, 95 (90%) fell below 23 Å, 79 (75%) fell below 19 Å. Only five of our high-confidence links (see Materials and methods) and two of low confidence cannot be explained with the crystal structure. This is apparently because of cross-linking being conducted in solution, allowing internal movement of protein regions that are fixed at certain positions in the crystal structure because of crystal lattice restraints. Indeed, six of these seven links involve residues with high B-factors in or proximal to the mobile clamp domain of Pol II ([Figure 1E](#f1){ref-type="fig"}; [Supplementary Figure S2](#S1){ref-type="supplementary-material"}). Thus, only a single lower confidence link appears to be false. We conclude that our cross-link analysis returns accurate distance constrains in the context of a large, multi-protein complex, with an experimentally determined error rate in the order of 1%, with 1 of the 106 observed cross-links being false.

Preparation and characterization of the Pol II--TFIIF complex
-------------------------------------------------------------

To subject the even larger, scarce, and fragile Pol II--TFIIF complex to cross-linking, we established a new protocol for its large-scale preparation. Extensive attempts to obtain *S. cerevisiae* TFIIF after co-expression of its subunits in *Escherichia coli* were unsuccessful. Previous purification of endogenous Pol II--TFIIF complex resulted in low yields and partially degraded Tfg1 ([@b10]). We therefore prepared a yeast strain that over-expresses the three TFIIF subunits and contains a tandem affinity purification (TAP) tag on Tfg2 (see Materials and methods). We could obtain up to 2 mg of pure Pol II--TFIIF complex after TAP and size exclusion chromatography.

Pol II--TFIIF complex preparations contained the 12 Pol II subunits and three TFIIF subunits in apparently stoichiometric amounts ([Figure 2A](#f2){ref-type="fig"}). Pol II was not phosphorylated, as judged from western blotting with antibodies specific against phosphorylation at the C-terminal repeat domain (CTD) residues Ser2, Ser5, or Ser7 ([Figure 2B](#f2){ref-type="fig"}). In an RNA extension assay (see Materials and methods and ([@b3]), the Pol II--TFIIF complex was as active as free Pol II ([Figure 2C](#f2){ref-type="fig"}). Thus, the new protocol provided previously unavailable amounts of pure, homogeneous, and catalytically active yeast Pol II--TFIIF complex.

Cross-link analysis of Pol II--TFIIF complex
--------------------------------------------

We next cross-linked and analysed the Pol II--TFIIF complex ([Figure 2D--F](#f2){ref-type="fig"}), comprising 15 subunits with a total molecular weight of 670 kDa. Using 200 μg of purified complex allowed for elaborate fractionation and more comprehensive analysis. We identified by MS 402 linkage sites of which 220 fell within TFIIF and 182 between Pol II and TFIIF ([Supplementary Tables 3](#S1){ref-type="supplementary-material"} and [4](#S1){ref-type="supplementary-material"}). Data covering residue pairs within Pol II were again obtained but not included in the analysis. The quality of the MS data allowed confident assignment of 224 linkage sites and revealed a further 178 sites with lower confidence. There was no confidence bias between intra- and inter-protein links. Of the 220 linkage sites within TFIIF 149 were within proteins and 71 between proteins. In total, 253 inter-protein and 149 intra-protein links were identified. In comparison, the previous study on the Ndc80 complex had identified 13 inter-protein and 12 intra-protein links ([@b36]). This advancement in number of detected linkage pairs apparently results from improved MS equipment including high-resolution fragmentation spectra, an additional fractionation step, and the larger size of the analysed complex, providing more possible linkage sites. The cross-link data obtained here for Pol II and Pol II--TFIIF complex are the largest collection to date and will provide a valuable resource to understand method-specific aspects such as the fragmentation behaviour of cross-linked peptides.

Yeast TFIIF domain structure
----------------------------

To build a model of the Pol II--TFIIF complex, we first modelled domains of yeast TFIIF based on the three known domain structures for human TFIIF ([Figure 3](#f3){ref-type="fig"}). We first obtained sequence alignments between the human and yeast sequences using HHPred ([@b50]) ([Supplementary Figure S3](#S1){ref-type="supplementary-material"}). We then modelled the yeast domains with program MODELLER. The sequence conservation for the two WH domains was high, making modelling straightforward. The Tfg1 WH domain spans residues 673--728, whereas the Tfg2 WH domain spans residues 292--354 ([Figure 3](#f3){ref-type="fig"}). For the Tfg1--Tfg2 dimerization domain, modelling was hampered because of low sequence conservation and uncertainty with respect to the N-terminal border of the domain in Tfg1 ([@b9]). The modelling suggested that the dimerization domain encompasses Tfg1 residues 98--400 with a non-conserved insertion at 167--305, and Tfg2 residues 55--227, with a non-conserved insertion at 144--192. Following the N-terminal dimerization domain, Tfg1 contains a 'charged region\' (residues 400--510).

The domain homology models, and the proposed domain structure of yeast TFIIF subunits, could be validated with the set of distance restraints within and between TFIIF subunits that were obtained as part of the cross-link analysis of the Pol II--TFIIF complex. The homology models for the three yeast TFIIF domains agree with the distance restraints provided by cross-links ([Figure 3B--D](#f3){ref-type="fig"}). We observed eight cross-links within the dimerization domain, four within the Tfg1 WH domain, and 15 within the Tfg2 WH domain. In the domain models, the cross-linked residue pairs are all within the permitted distance of 27.5 Å for C-α atoms. Taken together, the cross-linking and modelling reveal that the two large yeast TFIIF subunits form three structured domains in the Pol II-bound state. The N-terminal regions of subunits Tfg1 and Tfg2 form a dimerization domain, whereas WH domains are present in the C-terminal regions of the subunits.

Location of TFIIF on Pol II
---------------------------

The cross-linking with the Pol II--TFIIF complex revealed an extensive network of proximities between TFIIF subunits Tfg1 and Tfg2 and the second largest Pol II subunit Rpb2, whereas only few cross-links were observed, which involve other subunits ([Figure 2](#f2){ref-type="fig"}). TFIIF is positioned mostly on the Rpb2 side of the Pol II cleft ([Figure 4](#f4){ref-type="fig"}; [Supplementary Figure S4](#S1){ref-type="supplementary-material"}). The TFIIF dimerization domain is located at the Pol II lobe. The dimerization domain was placed manually on the Pol II surface, using only high-confidence cross-links and only cross-linking residues that were located either within the dimerization domain and Pol II structure or not more than 10 residues away in sequence. Enough spatial restraints were available to position and orient the dimerization domain ([Figure 4A](#f4){ref-type="fig"}; [Supplementary Figure S5](#S1){ref-type="supplementary-material"} and [Supplementary Table 5](#S1){ref-type="supplementary-material"}). One high-confidence cross-link is not satisfied by this position of the dimerization domain (Tfg1 394 to Rpb2 228). Satisfying this constraint moves the domain along its axis into the cleft, also agreeing with some previously reported evidence ([@b9]) ([Supplementary Figure S6](#S1){ref-type="supplementary-material"}). In this position, sufficient space remains for the DNA to pass below the domain. Satisfying this constraint, however, conflicts a number of constraints at the other end of the domain. The data hence support two overlapping positions for the dimerization domain and indicate residual mobility for this domain. This could indicate an open and closed form for the cleft with the TFIIF dimerization domain acting as a lid, open to allow entry of the DNA and closed during initial transcription.

TFIIF regions extending from the dimerization domain locate to neighbouring surfaces on Pol II. The Tfg1 region N-terminal to the dimerization domain cross-links to external 1 domain of Rpb2. The Tfg1 charged region C-terminal to the dimerization domain cross-links around the Rpb1 jaw at the downstream end of the cleft ([Figure 5](#f5){ref-type="fig"}).

The Tfg1 WH domain is apparently highly mobile, as no cross-links to Pol II were obtained. Our data on the Tfg2 WH domain and the dimerization domain show that cross-linking can capture dynamic structures. However, there is currently no data that establishes a limit beyond which interactions are too dynamic to be captured by cross-linking using *N*-hydroxysuccinimide esters, such as BS3 used in our study. The existence of an upper limit has been shown at least for formaldehyde cross-linking ([@b48]). Our data within the Tfg1 WH domain show that we are principally able to cross-link this domain and detect such cross-links. Absence of data linking this domain to the rest of the complex indicates therefore that cross-linking requires a minimal amount of interaction that is not present in this case. The domain being held in close proximity to the complex through the Tfg1 linker region alone is insufficient for detectable cross-linking.

The Tfg2 linker C-terminal to the dimerization domain extends along the Rpb2 protrusion over the side of Pol II. This path leads to cross-links of the Tfg2 WH domain with the protrusion on the upstream face of Pol II ([Figure 5](#f5){ref-type="fig"}). In the free Pol II--TFIIF complex, the Tfg2 WH domain is apparently not restricted to this location, as cross-links to the Pol II wall and clamp were also obtained. These interactions on wall and clamp are likely dynamic as the same sites also cross-link to the Tfg2 linker and C-terminal region ([Figure 4](#f4){ref-type="fig"}; [Supplementary Figure S7](#S1){ref-type="supplementary-material"}) and emphasize the ability of cross-linking to capture such transient interactions. Additional density at this location was observed in the previous EM structure ([@b10]). However, this alternative location of the Tfg2 WH domain cannot be adopted in an initiation complex, as it overlaps with the path of the DNA ([@b8]; [@b35]). Tfg2 WH binding at the protrusion is likely stabilized on binding of DNA and/or initiation factors. Subunit Tfg3 is apparently mobile, as only a few cross-links to the Pol II clamp were observed ([Figure 4](#f4){ref-type="fig"}; [Supplementary Table 3](#S1){ref-type="supplementary-material"} and [Supplementary Figure S4](#S1){ref-type="supplementary-material"}), consistent with previous cross-links of clamp residues to a small, not identified protein in PICs ([@b9]).

Discussion
==========

Architecture of the Pol II--TFIIF complex
-----------------------------------------

Knowing the three dimensional structure of the transcription initiation complex is of fundamental importance for our understanding of how gene promoters are recognized and used to start transcription. To arrive at the initiation complex structure, the location of the initiation factor modules on the Pol II surface must be determined. Here, we show for the first time that cross-linking and MS can be used to analyse spatial proximities within a large, 15-subunit 670 kDa multi-protein complex. This goes beyond the previously analysed four-subunit 176 kDa Ndc80 complex ([@b36]) and proves the value of this technology for the analysis of large multi-protein complexes.

Our work determines the three-dimensional architecture of the Pol II--TFIIF complex by use of a developing technology, cross-linking/MS, that shows the locations of the different parts of yeast TFIIF on the Pol II surface and reveals dynamic aspects of this interaction. The N-terminal Tfg1--Tfg2 dimerization domain anchors TFIIF on the Pol II lobe near the location of downstream DNA in initiation and elongation complexes ([@b8]; [@b30]). The C-terminal WH domains of Tfg1 and Tfg2 are mobile, but the Tfg2 WH domain can reside at the Pol II protrusion near upstream DNA in the initiation complex ([@b8]). The linker between the dimerization domain and the Tfg2 WH domain runs along the protrusion, whereas the charged region connecting the dimerization domain to the Tfg1 WH domain resides at the Rpb1 jaw.

Our results are consistent with previously reported cross-links between linker-containing amino acids in the TFIIF dimerization domain and the Pol II lobe ([@b9]), but not with most of the densities observed in the previous electron microscopic analysis of the Pol II--TFIIF complex ([@b10]). Our results significantly extend previous TFIIF location analysis as they suggest the orientation of the dimerization domain and the location of the other TFIIF regions. Modelling with the use of the previously reported initiation complex model ([@b8]) shows that our data are broadly consistent with the reported cross-links of human TFIIF subunits Rpb30 and Rap74 to promoter DNA positions −44 to −12 and −19 to −8, respectively, upstream of the transcription start site ([@b33]).

TFIIF function during transcription
-----------------------------------

Our results help to understand the mechanisms that TFIIF uses to accomplish its multiple functions during transcription. TFIIF has been implicated in the suppression of non-specific DNA binding to Pol II ([@b12]; [@b32]), in stable recruitment of promoter DNA to Pol II ([@b16]; [@b56]), in setting the transcription start site ([@b39]; [@b22]; [@b18]), and in the stimulation of early RNA elongation and the suppression of abortive transcription ([@b55]; [@b60]).

Non-specific DNA binding to Pol II likely occurs through association of DNA with the downstream cleft, because it is the only extensively positively charged surface on Pol II except for the hybrid site, which however binds A-form nucleic acids rather than B-DNA ([@b14]). DNA association with the cleft may be suppressed by either stabilizing a closed state of the clamp, or by transient occupancy of part of the cleft with a TFIIF domain. The cluster of cross-links between the downstream cleft and the charged region in Tfg1 ([Figures 3](#f3){ref-type="fig"} and [4](#f4){ref-type="fig"}) suggest that TFIIF may prevent non-specific DNA binding by placing an unstructured, predominantly negatively charged protein region in the cleft that repels DNA. Consistently, the bacterial initiation factor σ70 contains a negatively charged region (region 1.1) that also resides in the downstream cleft ([@b38]).

The function of TFIIF in promoter DNA recruitment may result at least in part from interactions of the WH domain in Tfg2 with promoter DNA upstream of the transcription start site. This domain has been implicated in DNA binding ([@b57]; [@b28]). Indeed, upstream DNA in an initiation complex would pass near the location of the Tfg2 WH domain on the protrusion ([Figure 5](#f5){ref-type="fig"}) ([@b8]). Some mobility of the WH domain may be required to allow for flexibility in DNA interactions to accommodate different promoters. The Tfg2 linker binds to the protrusion and apparently positions the Tfg2 WH domain in an initiation complex, explaining why the human Tfg2 homolog Rap30 is sufficient to recruit Pol II into an initiation complex ([@b16]). A resulting stabilization of the protrusion domain may at least in part underlie the ability of TFIIF to stimulate early elongation and to suppress abortive transcription, because the base of the protrusion domain is intimately connected with the domain binding the DNA--RNA hybrid.

Our results show that Tfg3 cross-links to the clamp of Pol II, which is not far from the CTD linker of Pol II revealed recently in *S. pombe* Pol II structure ([@b53]). Furthermore, interactions between Tfg1 WH and the CTD phosphatase Fcp1 were reported ([@b6]; [@b34]), suggesting a possible close proximity between the CTD of Pol II, Tfg1 WH, and Tfg3. The absence of any cross-link data involving the CTD is consistent with this entire region of the TFIIF--Pol II complex, including CTD, Tfg1 WH, and Tfg3, being highly mobile.

The function of TFIIF in setting the transcription start site likely results from a role in stabilizing an open promoter complex during scanning for an initiator sequence in the DNA template strand. Some mutations in TFIIF, which shift the start site, are located within the dimerization domain and destabilize this domain and reduce its binding to Pol II ([@b9]). Mutation of yeast Tfg1 residue E346 in the dimerization domain (D95 in human Rap74) has a defect in start site selection ([@b22]; [@b31]). Mutation of the adjacent residue G363 suppresses defects in start site selection caused by mutations in TFIIB or Rpb1 ([@b18]). Some mutations in Pol II, which shift the start site, are located in the lobe ([@b58]), and may also decrease the binding of the TFIIF dimerization domain. Loss of the Pol II subunit Rpb9 also leads to start site shifts ([@b63]), likely because Rpb9 buttresses the Rpb2 lobe ([Figure 5](#f5){ref-type="fig"}). Indeed, Rpb9 deletion decreases TFIIF binding affinity ([@b63]).

Our results show that the Tfg1 charged region binds to the Pol II cleft. This is consistent with a role of this domain in stimulating elongation ([@b29]), and explains why mutations in the charged region (human residues L155, I176, or M177) cause defects in stimulating formation of the first phosphodiester bond during initiation ([@b46]). This region likely resides at the base of the lobe and in the downstream cleft and may influence the conformation or dynamics of the mobile trigger loop at the floor of the polymerase cleft that together with the bridge helix constitutes the ratchet required for RNA synthesis and translocation.

Cross-linking and structural biology of large assemblies
--------------------------------------------------------

Protein cross-linking coupled to MS has allowed us to extend the Pol II structure to a 15-subunit, 670 kDa complex of Pol II with the initiation factor TFIIF at peptide resolution. We have shown the ability of cross-linking in conjunction with MS to capture interactions in a fragile complex of such size and thus expand our structural understanding from a stable complex core to the more elusive periphery. Furthermore, dynamic aspects of the Pol II--TFIIF complex have been captured. The absence of data placing the internally well-covered Tfg1 WH domain on the large Pol II surface indicates that cross-linking requires a minimum of specific interactions and structure. Our analysis reveals that cross-linking/MS has now reached a level of maturity that will see it integrate seamlessly with the established toolbox of integrated structural biology to increase our structural and mechanistic insight into large multi-protein complexes.

Materials and methods
=====================

Preparation of Pol II
---------------------

Endogenous complete Pol II was purified as described earlier ([@b54]) except that the final gel filtration step was performed in presence of buffer B (10 mM HEPES pH 8.0, 200 mM potassium acetate, 1 mM EDTA, 1 mM DTT, 10% glycerol). Fractions that contained pure and stoichiometric Pol II were concentrated to 0.7 mg/ml and flash-frozen in liquid nitrogen in buffer B containing 10% glycerol.

Preparation of Pol II--TFIIF complex
------------------------------------

A yeast over-expression cassette containing the *S. cerevisiae ADH1* promotor and terminator sequences was subcloned into *E. coli*--yeast shuttle integrative vectors YIplac128, YIplac204, and YIplac211 ([@b23]). These vectors contain markers (*LEU2*, *TRP1*, and *URA3*) that complement specific auxotrophic mutations in yeast strain DSY5 (Dualsystems Biotech) and allow selection of transformants containing the corresponding plasmids. Genes coding for yeast Tfg1, Tfg2, and Tfg3 were amplified from yeast genomic DNA and subcloned into plasmids YIplac128, YIplac204, and YIplac211, respectively. A TAP tag was added at the C-terminus of Tfg2. The YIplac204 plasmid was linearized with *Eco*RV within the *TRP1* gene, and used to transform the DSY5 strain. The resulting strain was recovered on YPD selective plate lacking tryptophan. From a single clone, a culture was grown and the corresponding cell pellet was transformed with the YIplac211 plasmid, linearized with *Stu*I restriction enzyme within the *URA3* gene. The resulting strain was recovered on a YPD selective plate lacking uracil and transformed with the YIplac128 plasmid, linearized with *Eco*RV within the *LEU2* gene. The resulting strain DSY5-Int3 was recovered on YPD selective plate lacking leucine and stored at −80°C.

The strain DSY5-Int3, which contained the genes for the three TFIIF subunits each under the control of the *ADH1* promotor, was grown overnight in a 200 l fermenter at 30°C. Cells were collected at OD600=3--4 and lysed by bead beating (BioSpec) in buffer A (50 mM Tris--HCl pH 7.5, 150 mM NaCl, 10 mM β-mercaptoethanol, 1 mM PMSF, 1 mM benzamidine, 200 μM pepstatin, 60 μM leupeptin). After filtration, the lysate was cleared by centrifugation (60 min, 8000 *g*), and ultracentrifugation (90 min, 30 000 *g*). The supernatant was incubated overnight at 4°C with IgG beads pre-equilibrated with buffer A. The protein was eluted by TEV cleavage and purified by size exclusion chromatography (Superose 6, GE Healthcare) in buffer B (10 mM HEPES pH 8.0, 200 mM potassium acetate, 1 mM EDTA, 1 mM DTT, 10% glycerol). Fractions that contained pure and stoichiometric Pol II--TFIIF complex were concentrated to 0.8 mg/ml and flash-frozen in liquid nitrogen in buffer B containing 10% glycerol.

RNA extension assays
--------------------

An amount of 4 pmol of complete Pol II or Pol II--TFIIF complex was incubated for 30 min at 20°C with 2 pmol of a pre-annealed with minimal nucleic acid scaffold (template DNA, 3′-GCTCAGCCTGGTCCG-5′; non-template DNA, 5′-CACACAGTCAG-3′; 6-carboxyfluoresceine (FAM) 5′ end-labelled RNA, 5′-UGCAUAAAGACCAGGC-3′). The complexes were incubated in the presence of 1 mM NTPs at 28°C for 20 min in transcription buffer (5 mM HEPES pH 7.3, 40 mM ammonium sulphate, 10 μM ZnCl~2~, 5 mM DTT). For gel electrophoresis, reactions were stopped by addition of an equal volume of 2 × loading buffer (8 M urea, 2 × TBE) and incubation for 5 min at 95°C. The FAM-labelled RNA extension products were separated by denaturing gel electrophoresis (0.5 pmol RNA per lane, 0.4 mm 15--20% polyacrylamide gels containing 8 M urea, 50--55°C) and visualized with a Typhoon 9400 phosphoimager (GE Healthcare).

Protein cross-linking
---------------------

The mixing ratio of BS3 to complex was determined for Pol II using 2.5 μg aliquots and using a protein-to-cross-linker molar ratio of 1:200, 1:600, 1:1800, 1:5400, and 1:16 200, respectively ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}). As the best condition we chose the ratio that was sufficient to convert most of the individual Pol II subunits into a high molecular weight band as judged by SDS--PAGE.

The purified Pol II complex (50 μl containing 35 μg) was mixed with 150 μg BS3 (Thermo Fisher Scientific) dissolved in 70 μl cross-link buffer (10 mM HEPES pH 8.0, 200 mM potassium acetate) and incubated on ice for 2 h. The reaction was stopped by adding 1 μl of 2.5 M ammonium bicarbonate for 45 min on ice. The reaction mix was separated on a NuPAGE 4--12% Bis--Tris gel using MES running buffer and Coomassie blue stain.

The purified TFIIF--Pol II complex (250 μl containing 200 μg) was mixed with 1 mg BS3 (Thermo Fisher Scientific) dissolved in 470 μl cross-link buffer (10 mM HEPES pH 8.0, 200 mM potassium acetate) and incubated on ice for 2 h. The reaction was stopped by adding 50 μl of 2.5 M ammonium bicarbonate for 45 min on ice. The reaction mix was separated on a NuPAGE 4--12% Bis--Tris gel using MES running buffer and Coomassie blue stain.

Sample preparation for MS analysis
----------------------------------

Bands from the SDS--PAGE gel corresponding to cross-linked complexes were excised and the proteins reduced/alkylated and digested using trypsin following standard protocols. In addition, for Pol II--TFIIF the area between the cross-linked complex and above the Rpb1 subunit was excised and analysed. The MS raw data for this fraction were combined with the main band and both were treated as one from thereon. Pol II cross-linked peptides were fractionated using SCX-StageTips ([@b27]) following the published protocol for linear peptides ([@b43]) and desalted using StageTips ([@b42]) before MS analysis. TFIIF--Pol II cross-linked peptides were desalted using StageTips and fractionated using strong cation exchange chromatography (200 × 2.1 mm Poly SULFOETHYLA column; Poly LC, Columbia, MD, USA) as described (Chen and Rappsilber, manuscript in preparation). Briefly, peptides were separated using solvent A (5 mM KH~2~PO~4~, 10% acetonitrile, pH 3.0), solvent B (solvent A with 1 M KCl), a flow rate of 200 μl/min, and a gradient consisting of 5 min at 100% solvent A followed by 20 min transition to 60% solvent B with a curve gradient (curve 8 equation, CHROMELEON software v.6.80; Dionex), 1 min at 60% solvent B. Fractions were collected every 1 min. Only fractions 14--26 were retained and desalted using StageTips for subsequent LC--MS/MS analysis.

Mass spectrometry
-----------------

Peptides were loaded directly onto the analytical column, packed with C18 material (ReproSil-Pur C18-AQ 3 μm; Dr Maisch GmbH, Ammerbuch-Entringen, Germany) using a self-assembled particle frit into the spray emitter ([@b26]), at a flow rate of 0.7 μl/min. A linear gradient going from 5% acetonitrile in 0.5% acetic acid to 23% acetonitrile in 0.5% acetic acid in 90 min eluted the peptides at 0.3 μl/min into an LTQ-Orbitrap classic. Peptides were analysed using a high/high strategy, detecting them at high resolution in the Orbitrap, and analysing their fragments also in the Orbitrap. FTMS spectra were recorded at 100 000 resolution. The three highest intensity peaks with a charge state of three or higher were selected in each cycle for iontrap fragmentation and Orbitrap detection of the fragments at 7500 resolution. Dynamic exclusion was set to 90 s and repeat count was 1. This resulted in a cycle time of up to 5 s and an average cycle time of 3 s.

Database searching
------------------

The MS raw files were processed into peak lists using MaxQuant ([@b13]) at default parameters except for 'top MS/MS peaks per 100 Da\' being set to 200. Searches were conducted against a database containing the sequences of the 12 Pol II subunits and the three TFIIF subunits from *S. cerevisiae* using in-house Xi program. Search parameters were MS accuracy, 6 ppm; MS/MS accuracy, 20 ppm; enzyme, trypsin; specificity, fully tryptic; allowed number of missed cleavages, four; fixed modifications, carbamidometylation on cysteine; variable modifications, oxidation on methionine and BS3 mono-link reacted with water or ammonia on lysine and protein N-termini. No linkage specificity of BS3 was assumed at the point of search. However, all identified peptides contained either a lysine residue or a protein N-terminus at the most likely linkage position as determined by observed fragments. As decoy search, 30 Da were subtracted from the mass of BS3. Post search filters of 3 ppm for the recalibrated precursor masses and 6 ppm for the recalibrated fragment masses were applied. The candidate sites as returned by automated matching of fragmentation spectra to cross-linked peptides were manually validated using in-house Xaminatrix program and sorted into high and low confidence. High confidence was attributed to a match of a cross-linked peptide to a spectrum when both peptides had at least four uniquely observed fragments and all major peaks of the spectrum were accounted for. Low confidence meant that one peptide was matching essentially all observed fragments and the second peptide had up to three observed fragments. All matches had to be highest ranking and unambiguous in the target and decoy search.
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![MS-coupled cross-linking analysis of Pol II. (**A**) SDS--PAGE analysis and (**B**) native gel electrophoresis of Pol II and BS3 cross-linked Pol II. Cross-linked Pol II was excised from the SDS--PAGE gel and analysed (red box). A higher-order linkage product (asterisk) was excluded, most likely corresponding to a Pol II dimer, also observed on the native gel in the absence and increased in the presence of cross-linker (asterisk). (**C**) High-resolution fragmentation spectrum of a cross-linked peptide. The linkage site Rpb2 K228--Rpb2 K246 was observed in the cross-linked peptide SALEK(xl)GSR/K(xl)AAPSPISHVAEIR (*m*/*z* 615.8439, 4+). Extensive ion series for both peptides are observed in the high-resolution fragmentation spectrum and provide high confidence in the match. (**D**) C-α distance distribution for experimentally observed lys--lys pairs (red bars) and a random probability distribution (blue bars) within Pol II. The approximate cross-link limit for BS3 of 27.4 Å is indicated by a dashed line. Observed links falling below this limit are in agreement with the X-ray structure of Pol II (PDB 1WCM); observed links exceeding this limit are potentially in conflict with the known structure. (**E**) Zoom into 1WCM showing Rpb2 K228 and Rpb2 K246 (red sphere). The link spans 33.1 Å and is thus 5.7 Å longer than the maximal distance the cross-linker plus side chains of lysine can bridge (27.4 Å). The crystallographic B-factor is 128 Å^2^ for Rpb2 K228 and 180 Å^2^ for Rpb2 K246, indicating both residues as likely mobile. Both residues are in loop regions.](emboj2009401f1){#f1}

![Preparation and MS-coupled cross-linking analysis of the complete Pol II--TFIIF complex. (**A**) SDS--PAGE analysis of pure Pol II--TFIIF complex. Protein identity was confirmed by MS (not shown). (**B**) Western blot analysis of the phosphorylation state of the Pol II CTD residues Ser2, Ser5, and Ser7; 10 μl of 5- or 20-fold dilutions of pure Pol II and Pol II--TFIIF complexes at 1 mg/ml were subjected to 6% SDS--PAGE. After blotting on a nitrocellulose membrane (GE Healthcare), dual labelling was performed with antibodies that recognize unphosphorylated CTD (8WG16, green) and antibodies 3E10, 3EB, and 4E12 ([@b7]), specific for phopshorylated CTD serines 2, 5, and 7 (Ser2P, Ser5P, and Ser7P, respectively). Yeast crude extract (CE) was used as control. (**C**) RNA extension assay of Pol II and Pol II--TFIIF *in vitro* (see Materials and methods). (**D**) SDS--PAGE analysis of Pol II--TFIIF complex and BS3 cross-linked Pol II--TFIIF complex. Cross-linked Pol II--TFIIF complex was excised from the SDS--PAGE gel in two bands and analysed (red box). (**E**) Native gel electrophoresis of BS3 cross-linked Pol II--TFIIF complex with BS3 cross-linked Pol II complex for comparison. The native gel shows absence of a dimer complex for BS3 cross-linked Pol II--TFIIF complex. (**F**) Cross-link map for TFIIF in complex with Pol II. Observed links from TFIIF to Pol II (dashed lines) are colour coded by the respective Pol II subunit. Links between TFIIF subunits (blue) and within TFIIF subunits (grey). For colour coding of domains in TFIIF see [Figure 3A](#f3){ref-type="fig"}.](emboj2009401f2){#f2}

![TFIIF domain architecture. (**A**) Schematic representation of TFIIF subunits and domains. Links between TFIIF subunits (blue) and within TFIIF subunits (grey). (**B**, **C**, **D**) Cross-links confirm domain modelling of yeast sequences into the human crystal structures for (**B**) the Tfg1 WH domain, (**C**) the Tfg2 WH domain, and (**D**) the dimerization domain of Tfg1 (blue) and Tfg2 (red). Lysine residues (sphere for c-α atom) and observed links (dashed lines, red for high confidence, grey for low confidence, green for inter-protein Tfg1--Tfg2) with distance found in the respective homology model.](emboj2009401f3){#f3}

![Architecture of the Pol II--TFIIF complex. (**A**) The TFIIF dimerization domain has been positioned on the Pol II surface based on a series of cross-links between Pol II and the dimerization domain. Cross-link sites on the Pol II surface (slate and pink, matching the colour code of the dimerization domain), cross-link sites in TFIIF (sphere for C-α atom), cross-links used for positioning the dimerization domain (red dashed line) and for validation (green dashed line). For linkage sites that are absent from the Pol II structure or the model of the Tfg1--Tfg2 dimerization domain the nearest residue that is present is highlighted and labelled together with an asterisk (compare with [Supplementary Table 3](#S1){ref-type="supplementary-material"} and [Supplementary Table 5](#S1){ref-type="supplementary-material"}). (**B**) Location of high-confidence cross-linking sites on Pol II surface coloured according to cross-linked TFIIF domains (represented in [Figure 3](#f3){ref-type="fig"}). The dimerization domain has been placed on the Pol II surface; the location of other TFIIF regions is indicated. Two views are used, the top view and the side view, related by a 90° rotation around the horizontal axis. For linkage sites that are absent from the Pol II structure or the model of the Tfg1--Tfg2 dimerization domain the nearest residue that is present is highlighted (compare with [Supplementary Table 3](#S1){ref-type="supplementary-material"} and [Supplementary Figures S4 and S5](#S1){ref-type="supplementary-material"}).](emboj2009401f4){#f4}

![Architecture of the Pol II initiation complex. Pol II is represented in top view. The path of the DNA in a closed promoter initiation complex is indicated as a thick grey line ([@b35]). Pol II subunits (left) and domains (right) are highlighted in canonical colours. The position of TFIIF regions is indicated. The point of attachment of the linker to the CTD of Rpb1 is depicted as an arrow.](emboj2009401f5){#f5}
